Clinical proteomics: translating benchside promise into bedside reality. - Wikidata - wikimedia - TriplyDB

Clinical proteomics: translating benchside promise into bedside reality.

Clinical proteomics: translating benchside promise into bedside reality.

http://www.wikidata.org/entity/Q34810370

about

A data review and re-assessment of ovarian cancer serum proteomic profiling Serum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapy.An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical management Epigenetics advancing personalized nanomedicine in cancer therapy Convergence of biomarkers, bioinformatics and nanotechnology for individualized cancer treatment Laser capture microdissection technology Biomarkers in cancer staging, prognosis and treatment selection Proteomics in uveal melanoma research: opportunities and challenges in biomarker discovery In silico elucidation of the molecular mechanism defining the adverse effect of selective estrogen receptor modulators Identification of direct target engagement biomarkers for kinase-targeted therapeutics Proteomic Characterization of Annexin l (ANX1) and Heat Shock Protein 27 (HSP27) as Biomarkers for Invasive Hepatocellular Carcinoma Cells Immune-enrichment of insulin in bio-fluids on gold-nanoparticle decorated target plate and in situ detection by MALDI MS Biomarker discovery: a proteomic approach for brain cancer profiling.From genomics to proteomics.Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations.Information content and analysis methods for multi-modal high-throughput biomedical data.Recursive SVM feature selection and sample classification for mass-spectrometry and microarray data.Identification of serum biomarkers for lung cancer using magnetic bead-based SELDI-TOF-MS.Proteomics in pathology research.Use of proteomic analysis to monitor responses to biological therapies.Protein arrays for studying blood cells and their secreted products.Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/ionization-based decision tree classification.Proteomics in nutrition research: principles, technologies and applications.Mass spectrometric identification of proteins in complex post-genomic projects. Soluble proteins of the metabolically versatile, denitrifying 'Aromatoleum' sp. strain EbN1.Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumors A potential biomarker in the cord blood of preterm infants who develop retinopathy of prematurity.Decision tree modeling predicts effects of inhibiting contractility signaling on cell motility Detection of venous thromboembolism by proteomic serum biomarkers.Proteomic analysis of two head and neck cancer cell lines presenting different radiation sensitivity.A robust biomarker discovery pipeline for high-performance mass spectrometry data.BioSunMS: a plug-in-based software for the management of patients information and the analysis of peptide profiles from mass spectrometry.Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures Challenges in the analysis of mass-throughput data: a technical commentary from the statistical machine learning perspective.Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer.A pilot study of proteomic profiles of human hepatocellular carcinoma in the United States.The role of proteomics in the diagnosis and treatment of ovarian cancer.Inflammatory biomarker profiling in elderly patients with acute hip fracture treated with heparins.Immunohistochemistry in diagnostic surgical pathology: contributions of protein life-cycle, use of evidence-based methods and data normalization on interpretation of immunohistochemical stains.Differential proteomics identification of HSP90 as potential serum biomarker in hepatocellular carcinoma by two-dimensional electrophoresis and mass spectrometry.

P2860

Q24806513-2436A9DF-2F30-4452-AF58-5543EAB92EEF Q24817009-6BC73327-E140-4E75-9161-2FBF822A37EB Q26784091-56E2E746-0C6D-4252-822E-EFF433C3444A Q26785379-CC708799-C536-4F6A-86EC-E3E8B5C47209 Q27010637-1034F5AA-C562-42B6-92AF-039315106141 Q28243455-7A34E809-8386-4375-AF10-449A09FA7946 Q28250373-DCE92342-89A2-414F-A8F7-1F3AEB9AA83E Q28278305-50EDD50B-BB06-460C-BE77-0560F0889229 Q28297411-42EED8AB-6711-443F-B6B9-D64332156AB3 Q28471679-D7D8A264-8D27-4CA3-8645-B37A3AE90795 Q28477593-61B1F09C-3BC0-4C40-B9B6-572DF1791C1C Q28550031-7E0BB733-84E3-4288-8086-8954B7EC11A4 Q28818783-7BB3B2CA-0CAB-487A-A698-CC8CAC971428 Q30159478-931EDAE0-4A0E-4989-908D-376F376F5880 Q30482453-6AD315DB-9BE6-4AAF-A1A3-AE86643C4A3C Q30751781-98E5489A-4221-488B-94EF-C9B78BAAA1AF Q30782019-15AA3050-0074-4ABD-8FBF-CD3C6F35A169 Q31036404-DD253598-E73C-4F0A-99CE-643630EB66F4 Q31039610-D950E2D8-E37F-46EE-B269-0107A594A467 Q31105602-D0DA7F7A-D9A1-42C7-AA0C-C6610F32217A Q33196034-C1A7D23B-7400-4201-8606-09646922D2C8 Q33213208-A3121181-46B8-46CF-BA1A-58379594181A Q33214577-DF16C394-B977-43F2-8EAF-315D01D0F189 Q33223706-2E8F558E-FCF5-4934-A84A-BB8E34655263 Q33249185-B364A7F5-D95A-4ADF-B506-517C619B93A3 Q33259880-2050AAE1-4A39-4133-8817-0FE5D798068E Q33269762-F283D5B7-0D77-4752-BCF8-E0232B20E859 Q33281143-D041C338-5A64-4AE7-8D07-F7A04DCAB14F Q33288265-C4066412-53FD-4A82-A6D3-A08E8D65945A Q33301649-F2C476DF-6216-4ADB-BBD4-A471167E2831 Q33302448-DF2E2BC4-4863-4B0C-9372-D8237D3BEBDF Q33409779-6CEA90C4-2DE8-497F-9EEB-C24233DEC607 Q33416583-C393D50E-1F7D-47DD-A75E-DD8F8E86ACFE Q33449305-EF0E8C5D-3921-45C3-8654-A718F6238E65 Q33450135-041292E6-CF6E-4A82-A9E9-40CAFBD23042 Q33470083-01F7A2FB-5FA2-46FE-81C2-41E76667EB31 Q33508672-C259E49B-1492-4AE1-AAB7-EA3296D3196A Q33517207-6D70DEBB-39A7-4857-AED4-0657F3DB38FE Q33529063-EB31E85C-F0EC-459C-8DEF-BD3BCBE7BBF6 Q33580269-75C07448-08F0-4132-8276-6782007291DD

P2860

Clinical proteomics: translating benchside promise into bedside reality.

http://www.wikidata.org/entity/Q34810370

description

2002 nî lūn-bûn

@nan

2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Clinical proteomics: translating benchside promise into bedside reality.

@ast

Clinical proteomics: translating benchside promise into bedside reality.

@en

Clinical proteomics: translating benchside promise into bedside reality.

@nl

type

label

Clinical proteomics: translating benchside promise into bedside reality.

@ast

Clinical proteomics: translating benchside promise into bedside reality.

@en

Clinical proteomics: translating benchside promise into bedside reality.

@nl

prefLabel

Clinical proteomics: translating benchside promise into bedside reality.

@ast

Clinical proteomics: translating benchside promise into bedside reality.

@en

Clinical proteomics: translating benchside promise into bedside reality.

@nl

P1433

Q34810370-B2C336B8-B782-4000-8226-306F29C95CA4

P1476

Q34810370-49EB4114-5A63-4C01-BEEB-CAF4BEA783A1

P2093

Q34810370-0BE4453F-DBF1-4619-BC65-FC3D06B66B07

Q34810370-4B98D538-1398-47B3-86ED-4751FE3B06B7

Q34810370-A1678840-4FD1-4C70-91D0-134547F9EA31

Q34810370-EDB56835-27F5-49E7-9B66-724B7C75EC83

Q34810370-F860283B-98D5-4C1A-9623-A7E0D9A19B64

P2860

Q34810370-08072E2C-1549-4C95-8835-E540E9E5EC72

Q34810370-0A2642C6-830D-49ED-B8E2-BF096DB3688F

Q34810370-0E053259-FFF0-499A-93EC-32E85D99F52B

Q34810370-18200E2B-1DA4-4C81-AB92-3AB0B61BFCF6

Q34810370-1FBA15FF-9020-4852-984F-02E3EA172FFC

Q34810370-2164CD2E-84EC-4EA9-861E-A99B44E087A5

Q34810370-26F042F9-7CCE-45AA-BA92-0B71045FCF30

Q34810370-2A051428-4B1C-4D60-ABD0-4D7070B8EF35

Q34810370-2C8A0414-753D-4487-9B55-7210C26772E1

Q34810370-2CFF3C8C-72A8-4F5C-9414-AA61F09CFA27

P2888

Q34810370-EAEA1695-D358-4020-82D4-8089E4FBE47D

P304

Q34810370-0D4C1A72-3B3B-42E0-B84F-E8F4B52728F8

P31

Q34810370-19C3BE6F-E63C-49F7-BED2-78F08691670D

P356

Q34810370-FDFC40C8-E0C6-4C4F-9AE9-55016435C3B9

P433

Q34810370-341FFBF5-1540-4631-BA3B-6DD4A58CA77A

P478

Q34810370-961CA3ED-6EF0-4D1A-8F0F-A0235AC6E23C

P577

Q34810370-2A1DAAAC-C728-4AA7-AD90-F82D3B6CB1FA

P6179

Q34810370-278A2650-8400-4F62-8466-5133F641BDC9

P698

Q34810370-FEA522CE-E659-4FFA-AE62-7073DDD7DD11

P356

P1433

Nature Reviews Drug Discovery

P1476

Clinical proteomics: translating benchside promise into bedside reality.

@en

P2093

Elise C Kohn

http://www.w3.org/2001/XMLSchema#string

Emanuel F Petricoin

http://www.w3.org/2001/XMLSchema#string

J Carl Barrett

http://www.w3.org/2001/XMLSchema#string

Kathryn C Zoon

http://www.w3.org/2001/XMLSchema#string

Lance A Liotta

http://www.w3.org/2001/XMLSchema#string

P2860

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Protein modules and signalling networks

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

Large-scale analysis of the yeast proteome by multidimensional protein identification technology

Quantitative analysis of complex protein mixtures using isotope-coded affinity tags

Proliferation, cell cycle and apoptosis in cancer

Oncogenic kinase signalling

Laser capture microdissection

Tissue microarrays for rapid linking of molecular changes to clinical endpoints

P2888

P304

683-695

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRD891

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2002-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1004955629

http://www.w3.org/2001/XMLSchema#string

P698

12209149

http://www.w3.org/2001/XMLSchema#string